NovaBridge Biosciences CMO Dennis Phillip Andrew sells 8,209 shares for $5,827.39
Bitget2026/09/21 20:05- NovaBridge Biosciences Chief Medical Officer Dennis Phillip Andrew reported an RSU settlement into 23,695 ordinary shares on Sep. 17.
- He sold 8,209 ordinary shares on Sep. 18 at USD 0.71 per share.
- Directly owned ordinary shares ended at 173,427 following the transactions.
- Directly held restricted share units stood at 72,120 after the Sep. 17 vesting.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Ekopak Expands Wastewater Treatment Plant at Mark Anthony Brewing
Vodafone (VOD.US) Swings to Loss in First Half, German Operations Major Drag
Vodafone (VOD.US) released its financial results for the first half of fiscal year 2027.
AI gamble backfires! Data center project writedowns and weak tech stock positions drag down SoftBank (SFTBY.US) to a Q2 loss of $7.1 billion
SoftBank recorded its first net loss in nearly two years due to a $3.7 billion impairment loss arising from a U.S. data center project, coupled with mounting market concerns over the sustainability of artificial intelligence (AI) growth impacting the investment giant’s key holdings.
AI Cloud Sector Faces a Key Moment: CoreWeave (CRWV.US) Set to Announce Earnings, Wells Fargo Remains Bullish
CoreWeave (CRWV.US) will release its third-quarter financial report after the U.S. stock market closes on Tuesday. This is seen as a key test for the strength of the new AI cloud sector.
Crypto prices
More
